To experimentally validate these findings, we initiated shRNA knockdown experiments targeting FOSL1 in the LUAD cell line H1299 and the PAAD cell line PANC-1 (Fig. 5b and Supplementary Table S8). This evidence concerns the gene FOSL1 and pancreatic adenocarcinoma.